16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
The U.S. District Court for the Eastern District of California has granted a request for a prelimina...
Read More >
Why This Matters - Last week, the California Supreme Court dealt tech giant Apple Inc. a blow when ...
Read More >
KEY LEGAL AND REGULATORY DEVELOPMENTS - Legislative and Regulatory Reform - Permanent reforms in...
Read More >
On January 28, 2020, the U.S. Federal Trade Commission (FTC), the agency charged with administering ...
Read More >
Main contractors often make claims against subcontractors for liquidated damages for delay. A questi...
Read More >
The Competition Tribunal has released extensive reasons for dismissing the abuse of dominance claim ...
Read More >